Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic-Uremic Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01433003
What this trial is testing

The Plasma Large-Volume Exchange RCT

Who this might be right for
Purpura, Thrombotic ThrombocytopenicHemolytic Uremic Syndrome
London Health Sciences Centre
Testing effectiveness (Phase 2)WithdrawnNCT03303313
What this trial is testing

An Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alnylam Pharmaceuticals
Not applicableStudy completedNCT01561248
What this trial is testing

Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis

Who this might be right for
Hemolytic Uremic SyndromeHemorrhagic ColitisIntestinal Infectious Disease+1 more
Universitätsklinikum Hamburg-Eppendorf 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05684159
What this trial is testing

Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy

Who this might be right for
aHUS - Atypical Hemolytic Uremic Syndrome
NovelMed Therapeutics 12
Not applicableLooking for participantsNCT04745195
What this trial is testing

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

Who this might be right for
Thrombotic MicroangiopathiesHemolytic Uremic Syndrome, AtypicalHemolytic-Uremic Syndrome
Maastricht University Medical Center 42
Post-approval studies (Phase 4)Looking for participantsNCT07308574
What this trial is testing

Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS

Who this might be right for
aHUSAtypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 20
Not applicableStudy completedNCT02336516
What this trial is testing

Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome

Who this might be right for
Haemolytic and Uremic Syndrome
Assistance Publique - Hôpitaux de Paris 148
Not applicableAvailableNCT02355782
What this trial is testing

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic Microangiopathy
Michal Nowicki
Not applicableLooking for participantsNCT07399730
What this trial is testing

Ravulizumab Outcomes in Polish Patients With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
AstraZeneca 80
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT05569746
What this trial is testing

Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS

Who this might be right for
Diarrhea-Associated Hemolytic Uremic SyndromePediatric Kidney DiseaseHemolytic-Uremic Syndrome
Inmunova S.A. 57
Not applicableEnded earlyNCT01522170
What this trial is testing

AHUS Observational Long Term Follow-Up

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 94
Not applicableLooking for participantsNCT05996731
What this trial is testing

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Who this might be right for
Atypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more
Mario Negri Institute for Pharmacological Research 105
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00838513
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT04132375
What this trial is testing

Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

Who this might be right for
Bloody DiarrheaSTEC, UnspecifiedHemolytic-Uremic Syndrome+1 more
Inmunova S.A. 11
Testing effectiveness (Phase 2)Study completedNCT00844844
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT00844428
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 5
Not applicableStudy completedNCT00360685
What this trial is testing

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

Who this might be right for
MucositisGraft-versus-host Disease
H. Lee Moffitt Cancer Center and Research Institute 89
Post-approval studies (Phase 4)Study completedNCT02574403
What this trial is testing

Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Nantes University Hospital 58
Next Page